PBIRx Celebrates Strategic Clinical Team Growth, Promotions, and Achievements

MILFORD, Conn.--(BUSINESS WIRE)-- PBIRx, Inc., a national leader in pharmacy benefit consulting and auditing, is proud to announce exciting updates reflecting the growth and strength of its Clinical Operations team.

Andrew Reis, RPh, MBA has been named Director of Clinical Consultants. With over 20 years of experience in pharmacy benefit management, Andrew brings deep industry knowledge and leadership expertise from prior roles at OptumRx, Catamaran, and NMHCRx. At PBIRx, he leads strategic clinical initiatives and enhanced client-tailored pharmacy benefit solutions.

Victoria Khavulya, PharmD, Senior Clinical Pharmacy Consultant, has earned a certificate in Gene Therapy from Harvard Medical School’s HMX Pro program. With a background in specialty pharmacy and complex therapies, Victoria’s expertise continues to elevate PBIRx’s clinical guidance, especially in areas like fertility care, oncology, and gene therapy.

Nabil Khan, PharmD recently completed a Pharmacogenomics Certificate, reinforcing PBIRx’s dedication to precision medicine and cutting-edge clinical strategies. Nabil’s enhanced skillset supports personalized medication management, improving outcomes and reducing costs for clients and members.

“These accomplishments reflect our continued investment in clinical excellence,” said Patricia Sirowich, President and Director of Clinical Operations. “We are proud of our exceptional clinical team’s diverse expertise and dedication to delivering high-impact, cost-effective pharmacy benefit solutions.”

PBIRx is committed to procuring top-tier talent and enhancing clinical offerings as evidenced by these exciting developments. The firm continues to strive to empower its team members through advanced education and certifications, enabling PBIRx to deliver unparalleled pharmacy benefit consulting services tailored to the unique needs of its clients.

About PBIRx

Our mission is to create optimal healthcare outcomes while minimizing overall healthcare costs. PBIRx is not a PBM. Since its founding as the first pharmacy benefit consulting and auditing firm in 1993, PBIRx has saved clients over $396 million, providing transparency and combating excessive profits of PBMs and pharmaceutical manufacturers. As a client advocate and educator, PBIRx’s primary goal is to manage pharmacy benefit costs for clients with a major sensitivity to their diverse cultures and needs. Our deep knowledge and advanced tools have helped us build lasting relationships and empower our clients to unravel the complexities of the ever-evolving pharmacy benefit industry. We are proud to be recognized as an Inc. 5000 fastest-growing company and hold SOC 2 Type 2 and SOC 3 attestation reports.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250918289215/en/

Media Contact:
Angela Cross
PBIRx Marketing Communications Manager
[email protected]
203-882-1188, ext. 220

Source: PBIRx, Inc.

You May Also Be Interested In

• David Hagan, Dean and Pegasus Professor at CREOL, The College of Optics and Photonics, Will Serve as Vice President of SPIE
• Better Together Podcast from GoldBear Media Goes Beyond the Highlight Reel to Explore the Real Stories Behind Entrepreneurship
• Wix.com Ltd. Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline